Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorCERNEA, Claudio R.-
dc.contributor.authorMATOS, Leandro Luongo-
dc.contributor.authorEUGENIO, Cecilia-
dc.contributor.authorFERREIRA, Giovanna Mattos-
dc.contributor.authorCERQUEIRA, Yasmin Sa-
dc.contributor.authorLEITE, Ana Kober N.-
dc.contributor.authorVANDERLEI, Felipe A. B.-
dc.contributor.authorCARLUCCI, Dorival de-
dc.contributor.authorGOTODA, Renato N.-
dc.contributor.authorHOJAIJ, Flavio C.-
dc.contributor.authorARAUJO-FILHO, Vergilius J. F.-
dc.identifier.citationCURRENT ONCOLOGY REPORTS, v.24, n.1, p.69-76, 2022-
dc.description.abstractPurpose of the Review There has been an increasing interest on active surveillance for papillary thyroid microcarcinomas (PTMC) in the literature. We will analyze the contributions of those authors who support this approach in most patients with low-risk tumors. Recent Findings The development of molecular methods to effectively detect aggressive PTMC at the fine-needle aspiration biopsy will enable the sound indication of immediate surgery in those patients, assuring the other individuals with the far more frequent indolent PTMC will undergo active surveillance with less anxiety. Several studies compared the quality of life between patients with PTMC who underwent active surveillance with immediate total thyroidectomy. However, thyroid lobectomy is a quite acceptable intermediate alternative for most patients with PTMC, with less surgical morbidity. Summary It is important to wait for worldwide validation, with reports from low- and middle-income areas, before recommending the routine adoption of active surveillance for patients with PTMC, due to difficult logistic obstacles in those environments.eng
dc.relation.ispartofCurrent Oncology Reports-
dc.subjectThyroid cancereng
dc.subjectPapillary thyroid microcarcinomaeng
dc.subjectWatchful waitingeng
dc.subjectActive surveillanceeng
dc.subject.otherpapillary microcarcinomaeng
dc.subject.otheraggressive variantseng
dc.titleActive Surveillance of Thyroid Microcarcinomas: a Critical Vieweng
dc.rights.holderCopyright SPRINGEReng
hcfmusp.publisher.cityNEW YORKeng
hcfmusp.publisher.countryUNITED STATESeng
hcfmusp.relation.referenceBastos AU, 2015, EUR J ENDOCRINOL, V173, P525, DOI 10.1530/EJE-15-0254eng
hcfmusp.relation.referenceCarling T, 2007, WORLD J SURG, V31, P916, DOI 10.1007/s00268-006-0837-3eng
hcfmusp.relation.referenceCernea CR, 2019, ARCH ENDOCRIN METAB, V63, P453, DOI 10.20945/2359-3997000000181eng
hcfmusp.relation.referenceChoi JS, 2009, AM J ROENTGENOL, V193, P871, DOI 10.2214/AJR.09.2386eng
hcfmusp.relation.referenceCibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LAeng
hcfmusp.relation.referenceD'Agostino TA, 2018, PSYCHO-ONCOLOGY, V27, P61, DOI 10.1002/pon.4383eng
hcfmusp.relation.referenceEsserman LJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4699eng
hcfmusp.relation.referenceHaugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020eng
hcfmusp.relation.referenceHwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227eng
hcfmusp.relation.referenceIto Y, 2003, THYROID, V13, P381, DOI 10.1089/105072503321669875eng
hcfmusp.relation.referenceIto Y, 2007, NAT CLIN PRACT ENDOC, V3, P240, DOI 10.1038/ncpendmet0428eng
hcfmusp.relation.referenceIto Y, 2018, THYROID, V28, P488, DOI 10.1089/thy.2017.0448eng
hcfmusp.relation.referenceIto Y, 2016, ENDOCR J, V63, P323, DOI 10.1507/endocrj.EJ15-0637eng
hcfmusp.relation.referenceIto Y, 2016, WORLD J SURG, V40, P523, DOI 10.1007/s00268-015-3184-4eng
hcfmusp.relation.referenceIto Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367eng
hcfmusp.relation.referenceIto Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0eng
hcfmusp.relation.referenceKhokhar MT, 2015, THYROID, V25, P1351, DOI 10.1089/thy.2015.0176eng
hcfmusp.relation.referenceKocher, 1909, CONCERNING PATHOLOGIeng
hcfmusp.relation.referenceKocher ET, 1883, ARCH KLIN CHIR, V29, P254eng
hcfmusp.relation.referenceKuo EJ, 2013, THYROID, V23, P1305, DOI 10.1089/thy.2012.0563eng
hcfmusp.relation.referenceLesnik D, 2014, HEAD NECK-J SCI SPEC, V36, P191, DOI 10.1002/hed.23277eng
hcfmusp.relation.referenceLi DP, 2016, J CELL BIOCHEM, V117, P1491, DOI 10.1002/jcb.25506eng
hcfmusp.relation.referenceLi F, 2015, ENDOCR-RELAT CANCER, V22, P159, DOI 10.1530/ERC-14-0531eng
hcfmusp.relation.referenceLin JF, 2020, SURGERY, V167, P110, DOI 10.1016/j.surg.2019.05.078eng
hcfmusp.relation.referenceLohia S, 2020, LARYNGOSCOPE INVEST, V5, P175, DOI 10.1002/lio2.356eng
hcfmusp.relation.referenceMiyauchi A, 2019, SURGERY, V165, P25, DOI 10.1016/j.surg.2018.07.045eng
hcfmusp.relation.referenceMolinaro E, 2020, J CLIN ENDOCR METAB, V105, pE172, DOI 10.1210/clinem/dgz113eng
hcfmusp.relation.referenceMoon JH, 2018, ENDOCRINOL METAB, V33, P278, DOI 10.3803/EnM.2018.33.2.278eng
hcfmusp.relation.referenceNickel B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4152-9eng
hcfmusp.relation.referenceNickel B, 2017, THYROID, V27, P661, DOI 10.1089/thy.2016.0483eng
hcfmusp.relation.referenceNiemeier LA, 2012, CANCER-AM CANCER SOC, V118, P2069, DOI 10.1002/cncr.26425eng
hcfmusp.relation.referenceOda H, 2016, THYROID, V26, P150, DOI 10.1089/thy.2015.0313eng
hcfmusp.relation.referenceOh HS, 2018, THYROID, V28, P1587, DOI 10.1089/thy.2018.0263eng
hcfmusp.relation.referencePollack R, 2021, J SURG RES, V258, P145, DOI 10.1016/j.jss.2020.08.061eng
hcfmusp.relation.referenceReinke R, 2019, CANCER EPIDEMIOL, V60, P46, DOI 10.1016/j.canep.2019.03.011eng
hcfmusp.relation.referenceRoss DS, 2014, THYROID, V24, P3, DOI 10.1089/thy.2013.0659eng
hcfmusp.relation.referenceSakai T, 2019, THYROID, V29, P59, DOI 10.1089/thy.2018.0462eng
hcfmusp.relation.referenceSawka AM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020298eng
hcfmusp.relation.referenceSchumm MA, 2021, SURGERY, V169, P282, DOI 10.1016/j.surg.2020.08.019eng
hcfmusp.relation.referenceShih PT, 2021, THYROID, V31, P1067, DOI 10.1089/thy.2020.0694eng
hcfmusp.relation.referenceSiddiqui S, 2016, THYROID, V26, P807, DOI 10.1089/thy.2015.0429eng
hcfmusp.relation.referenceSilver CE, 2011, HEAD NECK-J SCI SPEC, V33, P1052, DOI 10.1002/hed.21494eng
hcfmusp.relation.referenceSmulever A, 2021, ENDOCRINE, V72, P505, DOI 10.1007/s12020-020-02566-0eng
hcfmusp.relation.referenceStack BC, 2015, JAMA OTOLARYNGOL, V141, P957, DOI 10.1001/jamaoto.2015.2419eng
hcfmusp.relation.referenceSugitani I, 2021, THYROID, V31, P183, DOI 10.1089/thy.2020.0330eng
hcfmusp.relation.referenceTuttle RM, 2017, JAMA OTOLARYNGOL, V143, P1015, DOI 10.1001/jamaoto.2017.1442eng
hcfmusp.relation.referenceXue S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00736eng
hcfmusp.relation.referenceYabuta T, 2017, THYROID, V27, P1206, DOI 10.1089/thy.2016.0645eng
hcfmusp.relation.referenceZanocco KA, 2019, JAMA-J AM MED ASSOC, V321, P2020, DOI 10.1001/jama.2019.5350eng
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCG
Departamento de Cirurgia - FM/MCG

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/02
LIM/02 - Laboratório de Anatomia Médico-Cirúrgica

Artigos e Materiais de Revistas Científicas - LIM/08
LIM/08 - Laboratório de Anestesiologia

Artigos e Materiais de Revistas Científicas - LIM/28
LIM/28 - Laboratório de Cirurgia Vascular e da Cabeça e Pescoço

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)1.01 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.